Clinical trial
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating…
NCT00003578 · Lymphoma Trials Office, Other · Unknown status
Key facts
| NCT number | NCT00003578 |
|---|---|
| Title | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma |
| Official title | A Randomized Trial to Evaluate Early High Dose Therapy and Autologous Bone Marrow Transplantation as Part of Planned Initial Therapy for Poor Risk Intermediate/High Grade NHL |
| Lead sponsor | Lymphoma Trials Office, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | CHOP regimen, carmustine, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, melphalan, prednisone, vincristine sulfate, autologous bone marrow transplantation and 1 more |
| Enrollment | 500 |
| Start date | Jan 1, 1993 |
| First posted | Jan 27, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | Czechia, Denmark, Norway, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: